Display options
Share it on

Front Immunol. 2013 Apr 15;4:89. doi: 10.3389/fimmu.2013.00089. eCollection 2013.

The schistosoma granuloma: friend or foe?.

Frontiers in immunology

Emily Hams, Gabriella Aviello, Padraic G Fallon

Affiliations

  1. Trinity Biomedical Sciences Institute, School of Medicine, Trinity College Dublin Dublin, Ireland ; National Children's Research Centre, Our Lady's Children's Hospital Dublin, Ireland.

PMID: 23596444 PMCID: PMC3625856 DOI: 10.3389/fimmu.2013.00089

Abstract

Infection of man with Schistosoma species of trematode parasite causes marked chronic morbidity. Individuals that become infected with Schistosomes may develop a spectrum of pathology ranging from mild cercarial dermatitis to severe tissue inflammation, in particular within the liver and intestines, which can lead to life threatening hepatosplenomegaly. It is well established that the etiopathology during schistosomiasis is primarily due to an excessive or unregulated inflammatory response to the parasite, in particular to eggs that become trapped in various tissue. The eggs forms the foci of a classical type 2 granulomatous inflammation, characterized by an eosinophil-rich, CD4(+) T helper (Th) 2 cell dominated infiltrate with additional infiltration of alternatively activated macrophages (M2). Indeed the sequela of the type 2 perioval granuloma is marked fibroblast infiltration and development of fibrosis. Paradoxically, while the granuloma is the cause of pathology it also can afford some protection, whereby the granuloma minimizes collateral tissue damage in the liver and intestines. Furthermore, the parasite is exquisitely reliant on the host to mount a granulomatous reaction to the eggs as this inflammatory response facilitates the successful excretion of the eggs from the host. In this focused review we will address the conundrum of the S. mansoni granuloma acting as both friend and foe in inflammation during infection.

Keywords: Schistosoma mansoni; fibrosis; granuloma; immunology; inflammation

References

  1. J Infect Dis. 2005 Dec 1;192(11):1956-61 - PubMed
  2. J Immunol. 2001 Dec 1;167(11):6533-44 - PubMed
  3. J Exp Med. 2005 Nov 21;202(10):1319-25 - PubMed
  4. Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20459-64 - PubMed
  5. Nat Rev Immunol. 2012 Apr 20;12(5):352-66 - PubMed
  6. J Exp Med. 2012 Sep 24;209(10):1753-67, S1 - PubMed
  7. J Immunol. 1999 Apr 1;162(7):4122-32 - PubMed
  8. PLoS Pathog. 2009 Apr;5(4):e1000371 - PubMed
  9. Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13463-8 - PubMed
  10. J Immunol. 2007 May 15;178(10):6023-7 - PubMed
  11. J Immunol. 1997 Jul 15;159(2):777-85 - PubMed
  12. J Immunol. 2004 Aug 15;173(4):2419-27 - PubMed
  13. Am J Trop Med Hyg. 1977 Sep;26(5 Pt 1):944-56 - PubMed
  14. J Biol Chem. 2003 May 16;278(20):18384-92 - PubMed
  15. Mol Cell Proteomics. 2007 Sep;6(9):1485-99 - PubMed
  16. Infect Immun. 2011 Apr;79(4):1779-88 - PubMed
  17. PLoS Negl Trop Dis. 2011 Aug;5(8):e1269 - PubMed
  18. J Immunol. 1989 Mar 15;142(6):2061-6 - PubMed
  19. J Immunol. 2002 Jan 15;168(2):537-40 - PubMed
  20. Am J Respir Cell Mol Biol. 2003 Jul;29(1):106-16 - PubMed
  21. Am J Trop Med Hyg. 1997 May;56(5):515-21 - PubMed
  22. J Exp Med. 2010 Sep 27;207(10):2089-96 - PubMed
  23. Ann N Y Acad Sci. 2012 Apr;1253:E1-E13 - PubMed
  24. J Exp Med. 1998 Feb 16;187(4):619-29 - PubMed
  25. J Immunol. 1999 Jul 1;163(1):337-42 - PubMed
  26. Proc Natl Acad Sci U S A. 1990 Jan;87(1):61-5 - PubMed
  27. Infect Immun. 2006 Mar;74(3):1471-9 - PubMed
  28. Mol Immunol. 2007 Apr;44(10):2605-15 - PubMed
  29. Immunity. 2004 May;20(5):623-35 - PubMed
  30. Infect Immun. 1986 Dec;54(3):820-6 - PubMed
  31. Eur J Immunol. 2011 Sep;41(9):2677-87 - PubMed
  32. J Clin Invest. 1999 Sep;104(6):777-85 - PubMed
  33. Immunol Today. 2000 Jan;21(1):29-35 - PubMed
  34. PLoS Pathog. 2011 Oct;7(10):e1002272 - PubMed
  35. Trans R Soc Trop Med Hyg. 1981;75(1):41-53 - PubMed
  36. Trans R Soc Trop Med Hyg. 1981;75(1):54-71 - PubMed
  37. Blood. 2006 Oct 1;108(7):2420-7 - PubMed
  38. N Engl J Med. 2011 Sep 22;365(12):1141-4 - PubMed
  39. Braz J Med Biol Res. 1987;20(3-4):433-5 - PubMed
  40. Infect Immun. 2009 Jan;77(1):399-404 - PubMed
  41. J Immunol. 2000 Mar 1;164(5):2585-91 - PubMed
  42. Curr Opin Immunol. 1995 Aug;7(4):505-11 - PubMed
  43. Int J Parasitol. 2010 Apr;40(5):617-28 - PubMed
  44. Parasite Immunol. 2005 Jul-Aug;27(7-8):257-64 - PubMed
  45. Eur J Immunol. 1998 Apr;28(4):1408-16 - PubMed
  46. Immunology. 2005 Mar;114(3):410-7 - PubMed
  47. J Immunol. 1992 Sep 1;149(5):1714-22 - PubMed
  48. Nat Rev Immunol. 2002 Jul;2(7):499-511 - PubMed
  49. J Immunol. 2004 Dec 15;173(12):7454-61 - PubMed
  50. Mol Biochem Parasitol. 2005 Nov;144(1):123-7 - PubMed
  51. J Exp Med. 2009 Aug 3;206(8):1681-90 - PubMed
  52. J Immunol. 1983 Jan;130(1):418-22 - PubMed
  53. Nat Med. 2012 Nov;18(11):1665-72 - PubMed
  54. J Pathol. 1977 Jan;121(1):41-50 - PubMed
  55. PLoS Pathog. 2012 Dec;8(12):e1003063 - PubMed
  56. Acta Trop. 2008 Nov-Dec;108(2-3):135-8 - PubMed
  57. Parasitology. 1991 Oct;103 Pt 2:225-36 - PubMed
  58. Nat Struct Mol Biol. 2004 Jul;11(7):591-8 - PubMed
  59. J Infect Dis. 2013 Jan 1;207(1):186-95 - PubMed
  60. Nat Med. 2012 Jul 06;18(7):1028-40 - PubMed
  61. Parasitology. 2001 Mar;122(Pt 3):329-38 - PubMed

Publication Types